140 related articles for article (PubMed ID: 10654622)
1. Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
Brooks RR; Drexler AP; Maynard AE; Al-Khalidi H; Kostreva DR
Proc Soc Exp Biol Med; 2000 Feb; 223(2):183-9. PubMed ID: 10654622
[TBL] [Abstract][Full Text] [Related]
2. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction.
Drexler AP; Micklas JM; Brooks RR
J Cardiovasc Pharmacol; 1996 Dec; 28(6):848-55. PubMed ID: 8961084
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.
Buchanan LV; Kabell G; Brunden MN; Gibson JK
J Cardiovasc Pharmacol; 1993 Oct; 22(4):540-9. PubMed ID: 7505355
[TBL] [Abstract][Full Text] [Related]
5. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs.
Brooks RR; Finch SL
Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of isoproterenol-induced tachycardia by azimilide in the isolated perfused guinea pig heart.
Miller KE; Carpenter JF; Brooks RR
Cardiovasc Drugs Ther; 1998 Mar; 12(1):83-91. PubMed ID: 9607136
[TBL] [Abstract][Full Text] [Related]
7. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
[TBL] [Abstract][Full Text] [Related]
8. Atrial-selective antiarrhythmic actions of novel Ikur vs. Ikr, Iks, and IKAch class Ic drugs and beta blockers in pigs.
Knobloch K; Brendel J; Rosenstein B; Bleich M; Busch AE; Wirth KJ
Med Sci Monit; 2004 Jul; 10(7):BR221-8. PubMed ID: 15232496
[TBL] [Abstract][Full Text] [Related]
9. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia.
Brooks RR; Carpenter JF; Miller KE; Maynard AE
Proc Soc Exp Biol Med; 1996 May; 212(1):84-93. PubMed ID: 8618956
[TBL] [Abstract][Full Text] [Related]
11. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats.
Mittelstadt SW; Maynard AE; Benn DR; Lowe ER; Kostreva DR
Cardiovasc Drugs Ther; 1997 Sep; 11(4):591-8. PubMed ID: 9358964
[TBL] [Abstract][Full Text] [Related]
12. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM
Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982
[TBL] [Abstract][Full Text] [Related]
13. New advances in class III antiarrhythmic drug therapy.
Sager PT
Curr Opin Cardiol; 1999 Jan; 14(1):15-23. PubMed ID: 9932203
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Ducroq J; Rouet R; Puddu PE; Sallé L; Tabourel C; Ducouret P; Gérard JL
Eur J Pharmacol; 2005 Aug; 518(2-3):165-74. PubMed ID: 16083874
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
[TBL] [Abstract][Full Text] [Related]
16. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.
Carlsson L; Almgren O; Duker G
J Cardiovasc Pharmacol; 1990 Aug; 16(2):276-85. PubMed ID: 1697384
[TBL] [Abstract][Full Text] [Related]
17. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
[TBL] [Abstract][Full Text] [Related]
18. Azimilide dihydrochloride, a novel antiarrhythmic agent.
Karam R; Marcello S; Brooks RR; Corey AE; Moore A
Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
[TBL] [Abstract][Full Text] [Related]
19. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models.
Xue Y; Yamada C; Chino D; Hashimoto K
Eur J Pharmacol; 1999 Jul; 376(1-2):27-35. PubMed ID: 10440086
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall.
Yan GX; Wu Y; Liu T; Wang J; Marinchak RA; Kowey PR
Circulation; 2001 Jun; 103(23):2851-6. PubMed ID: 11401944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
